McKesson Corp. (MCK) News

McKesson Corp. (MCK): $386.85

7.13 (+1.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter MCK News Items

MCK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MCK News Highlights

  • MCK's 30 day story count now stands at 35.
  • Over the past 26 days, the trend for MCK's stories per day has been choppy and unclear. It has oscillated between 1 and 7.
  • ROSE, CAH and BRC are the most mentioned tickers in articles about MCK.

Latest MCK News From Around the Web

Below are the latest news stories about MCKESSON CORP that investors may wish to consider to help them evaluate MCK as an investment opportunity.

AmerisourceBergen (ABC) Hits 52-Week High: What's Driving It?

Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.

Yahoo | November 28, 2022

Boston Scientific (BSX) Posts Positive Post-Market Study Data

The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.

Yahoo | November 28, 2022

Is This Healthcare Giant a Buy for Dividend Growth Investors?

As a dividend growth investor, I am most focused on selecting great businesses with dependable profits. With a stake in the healthcare products distributor known as McKesson (NYSE: MCK) valued at $1.2 billion, the Oracle of Omaha seems to be impressed with the stock. Let's take a closer look at McKesson's fundamentals and valuation to address this question.

Yahoo | November 28, 2022

QIAGEN's (QGEN) New Monkeypox Test to Aid Faster Identification

QIAGEN's (QGEN) latest multiplex test is expected to strengthen its portfolio and boost its fight against the global monkeypox outbreak.

Yahoo | November 25, 2022

Here's Why You Should Retain Stryker (SYK) Stock For Now

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.

Yahoo | November 25, 2022

Zacks.com featured highlights include Archer-Daniels-Midland, McKesson, ParkerHannifin, Booz Allen Hamilton and Darden Restaurants

Archer-Daniels-Midland, McKesson, ParkerHannifin, Booz Allen Hamilton and Darden Restaurants are part of the Zacks Screen of the Week article.

Yahoo | November 25, 2022

Healthcare Distribution Global Market Report 2022: Ukraine-Russia War Impact

Major players in the healthcare distribution market are McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health Inc. , Owens & Minor Inc. , Morris and Dickson Co. LLC, KeySource Medical Inc. Major players in the healthcare distribution market are McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health Inc. , Owens & Minor Inc. , Morris and Dickson Co. LLC, KeySource Medical Inc.

GlobeNewswire | November 24, 2022

Alcon's (ALC) Latest Buyout to Enhance Its Product Portfolio

Alcon's (ALC) ophthalmic pharmaceutical product suite is expected to be significantly boosted by adding new products following the recent acquisition.

Yahoo | November 24, 2022

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.

Yahoo | November 24, 2022

3 Reasons to Retain QIAGEN (QGEN) Stock in Your Portfolio

Investors continue to be optimistic about QIAGEN (QGEN) on the back of a series of product launches.

Yahoo | November 23, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5876 seconds.